Virax Biolabs VRAX
NASDAQ VRAX
$1.37 -0.03 (-2.14%)
At close: Oct 20, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Receivables (2021 - 2025)

Updated

Virax Biolabs' Receivables was $729.00 in fiscal Q2 2026 (quarter ended Sep 30, 2025), down 69.1% from $2,361 a year earlier.

Analysis

Virax Biolabs (VRAX) Receivables (2021 - 2025) Analysis & Trends

At the end of FY2021 (ended Mar 31, 2021), Receivables at Virax Biolabs came in at -$53,569.

  • The fiscal Q2 2026 figure marks the lowest quarterly Receivables since fiscal Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn 11.14 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn 8.60 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn 3.97 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn 1.67 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn 6.36 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn 3.74 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn 3.05 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn 2.36 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 955.70 Mn
10 Virax Biolabs 536,746.51 -20.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 729.00
Sep 30, 2024 2,361.00
Mar 31, 2021 -53,569.00
API Access

Virax Biolabs Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=VRAX&period=max&api_key=YOUR_API_KEY